Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | CCR1 | P32246 | 2/20 | 0.42 |
| ▸ | CCR5 | P51681 | 2/20 | 0.42 |
| ▸ | CCR8 | P51685 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | METAP1 | P53582 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.42 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
| ▸ | TP53 | P04637 | 2/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30821345 | 1.00 | NPC1 (0.43) | NPC1ALDH1A1CYP2D6CYP2C19KDM4E | |
| SCHEMBL4190714 | 0.86 | KDM4E (0.50) | NPC1ALDH1A1CYP2D6CYP2C19KDM4E | |
| SCHEMBL29263724 | 0.86 | NPC1 (0.40) | NPC1ALDH1A1CYP2D6CYP2C19KDM4E | |
| SCHEMBL9214974 | 0.86 | NPC1 (0.40) | NPC1ALDH1A1CYP2D6CYP2C19KDM4E | |
| SCHEMBL3464071 | 0.82 | — | — | |
| SCHEMBL27333271 | 0.80 | NPC1 (0.44) | NPC1ALDH1A1CYP2D6CYP2C19KDM4E | |
| SCHEMBL4728794 | 0.79 | KDM4E (0.52) | NPC1ALDH1A1CYP2D6CYP2C19KDM4E | |
| SCHEMBL15617823 | 0.78 | NPC1 (0.43) | NPC1ALDH1A1CYP2D6CYP2C19KDM4E | |
| SCHEMBL1178754 | 0.78 | KDM4E (0.50) | NPC1ALDH1A1CYP2D6CYP2C19KDM4E | |
| SCHEMBL15911434 | 0.78 | NPC1 (0.43) | NPC1ALDH1A1CYP2D6CYP2C19KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104619700-A | Pyrazole carboxamide derivatives as TAAR modulators for the treatment of several diseases, such as depression, diabetes and Parkinson's disease | HOFFMANN LA ROCHE | 2015-05-13 | — | — | CN | disclosed |
| US-8877741-B2 | Pyrrolidine derivatives, pharmaceutical compositions and uses thereof | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2014-11-04 | — | — | US | disclosed |
| US-20140213568-A1 | Pyrrolidine derivatives, pharmaceutical compositions and uses thereof | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2014-07-31 | — | — | US | disclosed |
| CN-1281433-A | Hydroxamic acid derivatives as matrix metalloproteinase (MMP) inhibitors | PFIZER LTD (US) | 2001-01-24 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140213568-A1 | Pyrrolidine derivatives, pharmaceutical compositions and uses thereof | PEPD, PGA5, PYCR1 | NPC1 3595/4885ALDH1A1 1190/4885CYP2D6 172/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.